跳至主要内容
临床试验/NCT03696368
NCT03696368已完成不适用

Understanding Diverse Contributors to Gestational Diabetes Mellitus and Its Near-to-Long Term Consequences: An Indiana University Grand Challenges Precision Health Initiative Cohort Study (The Hoosier Moms Cohort)

Indiana University6 个研究点 分布在 1 个国家目标入组 411 人开始时间: 2019年1月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
411
试验地点
6
主要终点
GDM Diagnosis

研究概览

简要总结

The Hoosier Moms Cohort (HMC) study's goal is to better understand the pathophysiology underlying the development of gestational diabetes mellitus (GDM) in pregnant women and its transition to Type 2 diabetes mellitus in mothers and their exposed children.

The HMC study wants to determine what biomarkers (genetic, blood based and behavioral/interventional) can be identified in pregnant women affected with GDM and how those biomarkers can be used to impact preventative care.

详细描述

Predictive GDM genetic risk models will be tested and refined in the Hoosier Moms Cohort. In addition to prospectively using genetic information to predict GDM risk, the Hoosier Moms Cohort will incorporate the use of wearable/digital devices for collection of detailed behavioral information, support development of novel dietary capture methods, and enable the collection of specimens specifically aimed at multiple 'omics' techniques to engage in a detailed, multidimensional assessment of pathophysiologic pathways and biomarkers.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Singleton gestation
  • Gestational age ≤ 20+0 confirmed via American Congress of Obstetrics and Gynecology (ACOG) ultrasound dating guidelines
  • 18 years old or greater at time of consent

排除标准

  • Pre pregnancy diagnosis of Type 1 Diabetes or Type 2 Diabetes or Screening Hemoglobin A1C that is greater than or equal to 6.5% or two abnormal values on a 3 hours Oral Glucose Tolerance Test (100g load) before 20 weeks gestation
  • Pre pregnancy chronic usage of systemic steroids (inhaled and short term usage acceptable)
  • Planned pregnancy termination
  • Unable to provide informed consent in English or Spanish
  • Major fetal anomalies as listed below that are known prior to enrollment. If these are discovered after enrollment, the participant may be allowed to participate, unless the discovered fetal anomaly is a lethal anomaly.
  • Major Fetal Anomalies to be Excluded:
  • Congenital diaphragmatic hernia
  • Congenital cystic adenomatoid malformation
  • Pleural effusions
  • Chylothorax
  • Bronchogenic cyst
  • Bronchopulmonary sequestration
  • Anomalous pulmonary venous return
  • Tricuspid atresia
  • Mitral atresia
  • Double right ventricle
  • Ebstein's malformation
  • Pulmonary atresia
  • Hypoplastic left heart syndrome
  • Aortic coarctation
  • Fetal arrhythmias (tachycardia or bradycardia)
  • Transposition of the great vessels
  • Tetrology of Fallot
  • Double outlet right ventricle
  • Aortic stenosis
  • Holoprosencephaly
  • Anencephaly
  • Dandy-Walker malformation or variant
  • Septo-optic dysplasia
  • Neural tube defect
  • Vein of Galen aneurysm
  • Bilateral renal agenesis
  • Cystic renal disease (polycystic or multicystic)
  • Any genitourinary lesion accompanied by oligohydramnios at <24 weeks
  • Obstructive uropathy
  • Horseshoe kidney
  • Megacystis microcolon
  • Achondrogenesis
  • Thanatophoric dysplasia
  • Thoracic dysplasia
  • Osteogenesis imperfect
  • Short rib polydactyly
  • Any skeletal defect associated with small thorax
  • Hypophosphatemia
  • Any karyotypic abnormality
  • Any suspected genetic syndrome
  • Cleft lip/palate
  • Micrognathia
  • Fetal anemia (<35% on cordocentesis)
  • Neck mass
  • 另有 2 项未显示

结局指标

主要结局

GDM Diagnosis

时间窗: 42 weeks or less gestational age

Number of subjects diagnosed with GDM

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

David Haas

Professor of Obstetrics & Gynecology

Indiana University

研究点 (6)

Loading locations...

相似试验